Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma
- PMID: 24204132
- PMCID: PMC3817004
- DOI: 10.2147/CIA.S47350
Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma
Abstract
Glaucoma is a common eye disease in the aged population and has severe consequences. The present study examined the therapeutic effects of bone marrow mesenchymal stem cell (BMSC) transplantation in preventing loss of visual function in aged rats with glaucoma caused by laser-induced ocular hypertension. We found that BMSCs promoted survival of retinal ganglion cells in the transplanted eye as compared with the control eye. Further, in swimming tests guided by visual cues, the rats with a BMSC transplant performed significantly better. We believe that BMSC transplantation therapy is effective in treating aged rats with glaucoma.
Keywords: aging; cell therapy; glaucoma; stem cell; transplantation.
Figures



References
-
- Chrysostomou V, Rezania F, Trounce IA, Crowston JG. Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol. 2013;13(1):12–15. - PubMed
-
- Balaggan KS, Ali RR. Ocular gene delivery using lentiviral vectors. Gene Ther. 2012;19(2):145–153. - PubMed
-
- Wilson AM, Di Polo A. Gene therapy for retinal ganglion cell neuroprotection in glaucoma. Gene Ther. 2012;19(2):127–136. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical